Anti-tuberculosis treatment strategies and drug development: challenges and priorities
Author:
Publisher
Springer Science and Business Media LLC
Subject
General Immunology and Microbiology,Microbiology,Infectious Diseases
Link
https://www.nature.com/articles/s41579-022-00731-y.pdf
Reference195 articles.
1. Dorman, S. E. et al. Four-month rifapentine regimens with or without moxifloxacin for tuberculosis. N. Engl. J. Med. 384, 1705–1718 (2021).
2. Conradie, F. et al. Treatment of highly drug-resistant pulmonary tuberculosis. N. Engl. J. Med. 382, 893–902 (2020).
3. Young, C., Walzl, G. & Du Plessis, N. Therapeutic host-directed strategies to improve outcome in tuberculosis. Mucosal Immunol. 13, 190–204 (2020).
4. Perveen, S., Kumari, D., Singh, K. & Sharma, R. Tuberculosis drug discovery: progression and future interventions in the wake of emerging resistance. Eur. J. Med. Chem. 229, 114066 (2022).
5. World Health Organization. Global tuberculosis report 2020 (WHO, 2020).
Cited by 205 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Tuberculosis;Remington and Klein's Infectious Diseases of the Fetus and Newborn Infant;2025
2. The integration of omics: A promising approach to personalized tuberculosis treatment;Medicine in Omics;2024-12
3. Replacement of the essential nitro group by electrophilic warheads towards nitro-free antimycobacterial benzothiazinones;European Journal of Medicinal Chemistry;2024-12
4. Enhancing the therapeutic window for Spectinamide anti-tuberculosis Agents: Synthesis, Evaluation, and activation of phosphate prodrug 3408;Bioorganic & Medicinal Chemistry Letters;2024-11
5. Development of a proliposomal pretomanid dry powder inhaler as a novel alternative approach for combating pulmonary tuberculosis;International Journal of Pharmaceutics;2024-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3